Jazz Pharmaceuticals

-$1.55 (-1.02%) Today
$0.00 (0.00%) As of 11:59 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell JAZZ and other ETFs, options, and stocks.

About JAZZ

Jazz Pharmaceuticals Plc operates as a biopharmaceutical company, which focuses on the identification, development and commercialization of pharmaceutical products in the areas of narcolepsy, oncology, pain and psychiatry. Its product portfolio includes: Xyrem, Xywav, Sunosi, Erwinaze, Vyxeos, Defitelio, and Zepzelca.

CEO
Bruce C. Cozadd
Employees
3,200
Headquarters
Dublin, Dublin
Founded
2003

JAZZ Key Statistics

Market cap
9.40B
Price-Earnings ratio
—
Dividend yield
—
Average volume
531.37K
High today
$152.61
Low today
$149.54
Open price
$152.61
Volume
446.69K
52 Week high
$189.00
52 Week low
$117.64

JAZZ Earnings

$0.00
$1.44
$2.87
$4.31
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 2, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure